REGEN BIOPHARMA, INC. Debt Securities, Available-for-sale, Unrealized Loss
REGEN BIOPHARMA, INC. (RGBP) reported Debt Securities, Available-for-sale, Unrealized Loss of $33.60 thousand for the 3-month period ending 2015-09-30, per its 10-K/A filed 2017-04-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2017-04-28
- REGEN BIOPHARMA, INC. debt securities, available-for-sale, unrealized loss for the quarter ending 2015-09-30 was $33.60K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 3 month |
|---|---|
| 2015-09-30 | $33.60K 10-K/A · filed 2017-04-28 |